Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
MMS Stock Forecast 2026-2027
$98.32
Current Price
$5.54B
Market Cap
Buy 2
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to MMS Price Targets
+27.1%
To High Target of $125.00
+11.9%
To Median Target of $110.00
-3.4%
To Low Target of $95.00
MMS Price Momentum
+1.3%
1 Week Change
+12.7%
1 Month Change
+25.4%
1 Year Change
+13.9%
Year-to-Date Change
-0.5%
From 52W High of $98.83
+54.2%
From 52W Low of $63.77
📊 TOP ANALYST CALLS
Did MMS Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if MAXIMUS is one of their latest high-conviction picks.
Latest MMS Stock Price Targets & Analyst Predictions
Based on our analysis of 7 Wall Street analysts, MMS has a bullish consensus with a median price target of $110.00 (ranging from $95.00 to $125.00). The overall analyst rating is Strong Buy (8.0/10). Currently trading at $98.32, the median forecast implies a 11.9% upside. This outlook is supported by 2 Buy, 0 Hold, and 0 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
MMS Analyst Ratings
2
Buy
0
Hold
0
Sell
MMS Price Target Range
Low
$95.00
Average
$110.00
High
$125.00
Current: $98.32
Latest MMS Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for MMS.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Jan 2, 2025 | Raymond James | Brian Gesuale | Outperform | Upgrade | $90.00 |
| Jan 3, 2024 | Raymond James | Brian Gesuale | Market Perform | Downgrade | $N/A |
| Aug 18, 2023 | Stifel | Bert Subin | Buy | Initiates | $102.00 |
| Feb 9, 2023 | Raymond James | Brian Gesuale | Outperform | Maintains | $100.00 |
| May 6, 2022 | Raymond James | Brian Gesuale | Outperform | Maintains | $80.00 |
| Jun 28, 2021 | Raymond James | Brian Gesuale | Outperform | Downgrade | $105.00 |
| May 7, 2021 | Raymond James | Brian Gesuale | Strong Buy | Maintains | $110.00 |
| Apr 22, 2021 | Canaccord Genuity | Hold | Maintains | $95.00 | |
| Feb 5, 2021 | Raymond James | Brian Gesuale | Strong Buy | Maintains | $96.00 |
| Aug 7, 2020 | Keybanc | Overweight | Maintains | $84.00 | |
| Aug 7, 2020 | KeyBanc | Overweight | Maintains | $N/A | |
| Jul 8, 2020 | Raymond James | Strong Buy | Upgrade | $N/A | |
| Jun 24, 2020 | KeyBanc | Overweight | Upgrade | $N/A | |
| Jun 24, 2020 | Keybanc | Overweight | Upgrade | $N/A | |
| Jan 8, 2020 | Wells Fargo | Jamie Stockton | Equal-Weight | Maintains | $81.00 |
| Aug 13, 2019 | Canaccord Genuity | Hold | Maintains | $77.00 | |
| Aug 9, 2019 | Wells Fargo | Market Perform | Downgrade | $N/A | |
| Oct 10, 2018 | Canaccord Genuity | Richard Close | Hold | Maintains | $67.00 |
| May 11, 2018 | Canaccord Genuity | Richard Close | Hold | Maintains | $64.00 |
| May 8, 2018 | First Analysis | Overweight | Upgrade | $N/A |
Maximus Inc. (MMS) Competitors
The following stocks are similar to MAXIMUS based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Maximus Inc. (MMS) Financial Data
Maximus Inc. has a market capitalization of $5.54B with a P/E ratio of 17.8x. The company generates $5.43B in trailing twelve-month revenue with a 5.9% profit margin.
Revenue growth is +0.2% quarter-over-quarter, while maintaining an operating margin of +6.3% and return on equity of +18.1%.
Valuation Metrics
Market Cap
$5.54B
Enterprise Value
$6.58B
P/E Ratio
17.8x
PEG Ratio
1.5x
Price/Sales
1.0x
Growth & Margins
Revenue Growth (YoY)
+0.2%
Gross Margin
+25.3%
Operating Margin
+6.3%
Net Margin
+5.9%
EPS Growth
+3.8%
Financial Health
Cash/Price Ratio
+4.2%
Current Ratio
1.6x
Debt/Equity
86.4x
ROE
+18.1%
ROA
+8.1%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Maximus Inc. (MMS) Business Model
About Maximus Inc.
What They Do
Provides health and human services solutions.
Business Model
Maximus Inc. generates revenue by offering business process services to government programs, focusing on administrative solutions and consultancy in sectors like healthcare, welfare, and employment. The company partners with governments to enhance service delivery and compliance in programs such as Medicaid and Medicare.
Additional Information
Headquartered in Reston, Virginia, Maximus plays a crucial role in optimizing public sector operations globally. The company is dedicated to improving citizen engagement and access to services, contributing significantly to public health and economic resilience through its technological and strategic expertise.
Company Information
Sector
Industrials
Industry
Specialty Business Services
Employees
37,200
CEO
Mr. Bruce L. Caswell
Country
United States
IPO Year
1997
Website
www.maximus.comMaximus Inc. (MMS) Latest News & Analysis
Featured Analysis
Powered by
Zacks Investment Research
Should Value Investors Buy Maximus (MMS) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Jan 16, 2026
By Zacks Equity Research
Tale of the Tape
Are Business Services Stocks Lagging APi Group (APG) This Year?
Here is how APi (APG) and Maximus (MMS) have performed compared to their sector so far this year.
Jan 16, 2026
By Zacks Equity Research
Tale of the Tape
Here's Why Maximus Stock is a Compelling Pick for You Right Now
MMS shares have climbed 11.3% over the past month, beating the industry. Rising estimates, earnings beats and steady revenue growth drive momentum.
Jan 14, 2026
By Zacks Equity Research
Analyst Blog
Latest News
Quick Summary
MMS shares rose 11.3% in the past month, outperforming the industry, due to increasing estimates, earnings beats, and consistent revenue growth.
Why It Matters
MMS's 11.3% share increase signals strong performance, outpacing peers. Rising estimates and earnings beats suggest robust future growth, making it an attractive investment opportunity.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Maximus will hold its FY26 first quarter earnings call on February 5, releasing financial results that morning.
Why It Matters
Maximus's upcoming earnings call on February 5 will provide key insights into its financial performance, influencing investor sentiment and stock valuation.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Zacks Style Scores can help investors identify strong, market-beating stocks for their portfolios.
Why It Matters
Zacks Style Scores can help identify high-potential stocks, aiding investors in making informed decisions to enhance portfolio performance and outperform the market.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Maximus announced a quarterly cash dividend of $0.33 per share, marking a 10% increase from the previous dividend.
Why It Matters
Maximus's 10% dividend increase signals strong financial health and commitment to returning value to shareholders, potentially attracting more investors and boosting stock prices.
Source: Business Wire
Market Sentiment:
Neutral
New Strong Buy Stocks for January 5th
13 days ago
Quick Summary
KVYO, MMS, CCBG, BAP, and LGGNY were added to the Zacks Rank #1 (Strong Buy) List on January 5, 2026.
Why It Matters
Stocks added to the Zacks Rank #1 (Strong Buy) List typically indicate strong performance potential, attracting investor interest and potentially driving up share prices.
Source: Zacks Investment Research
Market Sentiment:
Positive
Best Value Stocks to Buy for January 5th
13 days ago
Quick Summary
OI, MMS, and ALGT were added to the Zacks Rank #1 (Strong Buy) value stocks list on January 5, 2026.
Why It Matters
Zacks Rank #1 indicates strong growth potential and positive market sentiment for OI, MMS, and ALGT, suggesting likely outperforming investments.
Source: Zacks Investment Research
Market Sentiment:
Positive
Frequently Asked Questions About MMS Stock
What is Maximus Inc.'s (MMS) stock forecast for 2026?
Based on our analysis of 7 Wall Street analysts, Maximus Inc. (MMS) has a median price target of $110.00. The highest price target is $125.00 and the lowest is $95.00.
Is MMS stock a good investment in 2026?
According to current analyst ratings, MMS has 2 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $98.32. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for MMS stock?
Wall Street analysts predict MMS stock could reach $110.00 in the next 12 months. This represents a 11.9% increase from the current price of $98.32. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Maximus Inc.'s business model?
Maximus Inc. generates revenue by offering business process services to government programs, focusing on administrative solutions and consultancy in sectors like healthcare, welfare, and employment. The company partners with governments to enhance service delivery and compliance in programs such as Medicaid and Medicare.
What is the highest forecasted price for MMS Maximus Inc.?
The highest price target for MMS is $125.00 from at , which represents a 27.1% increase from the current price of $98.32.
What is the lowest forecasted price for MMS Maximus Inc.?
Price targets from Wall Street analysts for MMS are not currently available. The stock is trading at $98.32.
What is the overall MMS consensus from analysts for Maximus Inc.?
The overall analyst consensus for MMS is bullish. Out of 7 Wall Street analysts, 2 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $110.00.
How accurate are MMS stock price projections?
Stock price projections, including those for Maximus Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: January 18, 2026 4:07 PM UTC